Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Convex endobronchial ultrasound bronchoscope may enhance visualization and diagnosis by respiratory physicians: Clinical image of an endoscopic ultrasound with bronchoscope.
Matsuoka S, Takigawa Y, Sato K, Inoue T, Watanabe H, Kudo K, Sato A, Fujiwara K, Shibayama T. Matsuoka S, et al. Among authors: sato k. Respirol Case Rep. 2024 Nov 25;12(11):e70072. doi: 10.1002/rcr2.70072. eCollection 2024 Nov. Respirol Case Rep. 2024. PMID: 39588326 Free PMC article.
Association between sodium-glucose cotransporter-2 inhibitor and adverse events in patients with moderate to severe chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials.
Mitsuboshi S, Hitoshi K, Ominato A, Kinoshita T, Sugimoto Y, Kajiwara-Morita A, Urata M, Sato K, Sakamaki T. Mitsuboshi S, et al. Among authors: sato k. Eur J Clin Pharmacol. 2024 Nov 23. doi: 10.1007/s00228-024-03779-2. Online ahead of print. Eur J Clin Pharmacol. 2024. PMID: 39579179 Review.
Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.
Sheth KN, Albers GW, Saver JL, Campbell BCV, Molyneaux BJ, Hinson HE, Cordonnier C, Steiner T, Toyoda K, Wintermark M, Littauer R, Collins J, Lucas N, Nogueira RG, Simard JM, Wald M, Dawson K, Kimberly WT; CHARM Trial investigators. Sheth KN, et al. Lancet Neurol. 2024 Dec;23(12):1205-1213. doi: 10.1016/S1474-4422(24)00425-3. Lancet Neurol. 2024. PMID: 39577921 Clinical Trial.
Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis.
Taguchi S, Kawai T, Ambe Y, Kishitani K, Noda M, Kaneko T, Miyakawa J, Nakamura Y, Hoshina H, Obinata D, Yamaguchi K, Kakutani S, Furuya Y, Sato Y, Adachi Y, Sugimoto K, Sato K, Tabata M, Tanaka T, Nara K, Uemura Y, Kamei J, Akiyama Y, Sato Y, Yamada Y, Niimi A, Yamada D, Takada T, Takahashi S, Yamada Y, Miyazaki H, Enomoto Y, Nishimatsu H, Fujimura T, Fukuhara H, Nakagawa T, Takahashi S, Kume H. Taguchi S, et al. Among authors: sato k. Int J Urol. 2024 Nov 22. doi: 10.1111/iju.15640. Online ahead of print. Int J Urol. 2024. PMID: 39575880
15,221 results
You have reached the last available page of results. Please see the User Guide for more information.